Browse by author
Lookup NU author(s): Deena Harji, Dr Abigail Vallance, Temi Ibitoye
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2024 Association of Coloproctology of Great Britain and Ireland. Aim: Locally advanced and recurrent colorectal cancer represents a complex clinical entity, which requires multidisciplinary decision-making and management. The aim of this work is to understand the provision of clinical services in this cohort of patients across Great Britain and Ireland (GB&I) as a key essential step to help facilitate future service development and improvement. Method: A cross-sectional, organizational survey was sent to all colorectal cancer multidisciplinary teams (MDTs) across GB&I. It consisted of 12 key questions addressing the provision of specialist services and advanced surgical techniques. Results are reported in line with the CHERRIES guideline. Results: One hundred and seventy-five MDTs across GB&I participated, with 142 English, 13 Welsh, 14 Scottish, 3 Northern Irish and 3 Irish MDTs. The overall response rate was 93.5% (175/187). Ninety (51.4%) hospital sites reported having a specialist dedicated or subsection MDT. Specialist advanced nursing support was available in 46 (26.2%) hospitals, with a dedicated advanced colorectal cancer outpatient clinic available in 31 (17.7%) hospitals. One hundred and thirteen MDTs (64.5%) offered surgery for advanced colonic cancer, 82 (46.8%) for recurrent colonic cancer, 58 (33.1%) for advanced rectal cancer and 39 (22.2%) for recurrent rectal cancer. A variable number of MDTs offered specialist surgical techniques, including distal sacrectomy [33 (18.9%)], high sacrectomy [16 (9.1%)], complex vascular resection ± reconstruction [33 (18.9%)] and extended lymphadenectomy (pelvic sidewall or para-aortic) [44 (25.1%)]. Conclusion: The IMPACT organizational survey highlights the current variation in the delivery and provision of clinical services for patients with advanced and recurrent colorectal cancer across Great Britain and Ireland.
Author(s): Harji D, Vallance A, Ibitoye T, Wilkin R, Boyle J, Clifford R, Convie L, Duff M, Elavia K, Evans M, Fleming C, Griffiths B, Jenkins JT, Mohan H, Morris EJ, Taylor C, Thorpe G, Tiernan J, Fearnhead N, Agarwal T, Aryal K, Beaton C, Bhalla A, Branagan G, Chapple K, Clouston H, Coyne P, Day A, Eccersley J, Ferguson H, George ML, George R, Hamilton E, Hornung B, Khan RBN, Keeler B, Linn T, McArthur D, McDermott F, McFall M, Mills SJ, O'Leary D, Paraoan MT, Rahman-Casans SF, Rajendran N, Ramwell A, Rout S, Rutter MD, Sadat MM, Sallomi D, Samad A, Skaife P, Slater R, Solkar M, Speake W, Symons N, Telford K, Ward N, Westwood D, Wilde M, Wilson J, Younis F
Publication type: Article
Publication status: Published
Journal: Colorectal Disease
Year: 2024
Pages: ePub ahead of print
Online publication date: 22/10/2024
Acceptance date: 22/09/2023
ISSN (print): 1462-8910
ISSN (electronic): 1463-1318
Publisher: John Wiley and Sons Inc.
URL: https://doi.org/10.1111/codi.17139
DOI: 10.1111/codi.17139
PubMed id: 39435558
Altmetrics provided by Altmetric
